resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.
Gastroenterology
Pediatric split liver transplant surgery is rare, with only 10 U.S. centers offering it. Children’s Health began using technically variant grafts in 2024 and has since doubled the national average, expanding access and reducing waitlist mortality.
Cardiology, +1 more
The Pediatric Cardio-Oncology Program at Children’s Health is one of the first in the nation offering a dedicated clinic focused on protecting the heart health of children battling cancer or in remission.
Gastroenterology
Learn how Children’s Health collaborated on the first-ever global guidelines for pediatric IBS and functional abdominal pain, offering gastroenterologists evidence-based recommendations to improve care for gut-brain interaction disorders.
Neonatology
Standard NICU care prioritizes the infant, but parents’ perceptions of vulnerability can affect development. A new Children’s Health study shows cognitive behavioral therapy can reduce parental perceived child vulnerability after NICU discharge.
Nephrology
Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder that causes excess oxalate, leading to kidney failure and systemic damage. While liver transplant is the only cure, FDA-approved therapies are making kidney-only transplants a viable option.
Neurology
New study at Children’s Health confirms the safety of sampling thalamic nuclei during SEEG in pediatric patients with drug-resistant epilepsy (DRE). The findings revealed that accurate thalamic mapping can improve neuromodulation targeting.
Behavioral Health
The Behavioral Health Vehicles Program at Children’s Health provides emergency transport services to children with mental health needs.
Pulmonology
This episode focuses on obstructive sleep apnea in children with cystic fibrosis and the critical need for proactive screening.
Children’s Health helped develop a first-of-its-kind tool for diagnosing familial chylomicronemia syndrome (FCS) and contributed to an expert consensus on treatment approaches. Discover how this is improving pediatric FCS care.
Pediatric stroke, aneurysm, AVM and moyamoya disease require fast, coordinated care across subspecialties. See how Children's Health is transforming outcomes through on-site intervention capability, integrated decision-making and long-term follow-up.
Learn how Children’s Health built the nation’s only “fetus-to-five” neonatal brain program – integrating prenatal, neuroNICU and follow-up care to improve outcomes for high-risk infants.
Children’s Health research showed that a combination chemotherapy-immunotherapy treatment is safe in children with solid tumors. A new trial is assessing the treatment’s efficacy in patients with relapsed and refractory rhabdomyosarcoma.
Children’s Health research shows observation is a safe initial approach for pediatric cervicofacial NTM lymphadenitis. A retrospective study found most cases resolve without intervention.
Gastroenterology
Research led by Children’s Health reveals the esophageal microbiome as an active immunologic environment, with disease-specific microbial patterns that may inform biomarker development, earlier diagnosis and targeted therapies.
Hematology & Oncology
Pediatric fertility preservation now includes advanced options giving hope to even the youngest patients. Our experts share their insights, based on years of experience at the leading edge of this rapidly evolving field.
Pulmonology
A study from Children’s Health provides insight on the timeline from tracheostomy to respiratory independence for children with bronchopulmonary dysplasia – and several keys to supporting their health and growth along the way.
Clinical Trial
This study is a multi-center RCT to determine whether use of the FAST examination impacts care in hemodynamically stable children with blunt torso trauma.
Neurology
This trial in children with suspected focal cerebral arteriopathy (FCA) presenting with arterial ischemic stroke (AIS) or transient ischemic attack (TIA) comparing early corticosteroid treatment versus delayed/no corticosteroid treatment.
Nephrology
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia.
Neurology
The study is being conducted in order to evaluate objective change in cognition and expressive language after implant and therapy with the Inspire UAS System.
Hematology & Oncology
Each patient will be randomly assigned to receive either extended half-life factor VIII based replacement therapy or non-FVIII based replacement therapy, which are both standard of care treatment for persons with Hemophilia A.
Cardiology
This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 of the Base Period.
Pulmonology
This is a prospective multicenter randomized interventional trial. Participants will be randomized to receive either an SPS or DAS.
Cardiology
The overall study design is a prospective clinical trial that combines two individual study designs into one common protocol.
resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.